Digital Diabetes Management : Emerging Innovations and New Technologies Transforming the Healthcare Business

The wearable devices segment is expected to account for the largest share of the digital diabetes management market.

The large share of the market is mainly due to factors such as the increasing number of regulatory approvals for CGM systems; technological advancements such as closed-loop pump systems, smart insulin patches, and other pipeline devices; and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery in diabetes management.

North America to offer investment opportunities:

This is due to the growing demand for technologically advanced solutions such as closed-loop systems, high adoption of remote online coaching services for diabetes management, high adoption of connected diabetes management devices and apps, favorable reimbursement policies, increased acceptance of digital diabetes solutions from payers, rising awareness on self-diabetes management and government initiatives to promote digital health in the region.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893

digital diabetes management

Prominent players in the global digital diabetes management market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).

Medtronic

Medtronic is the leading provider of digital diabetes management solutions across the globe. The company offers a portfolio of health information exchange solutions, clinical decision support solutions, and telehealth solutions and services to meet the needs of patients and physicians working in the areas of diabetes management. The company focuses on developing integrated devices that enable data sharing between devices, patients, care providers, and healthcare professionals to help generate actionable insights.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=144725893

To improve patient experience, the company focuses on growth strategies, such as collaborations, partnerships, agreements, and acquisitions. Additionally, it also focuses on enhancing and launching products to strengthen its product portfolio. For instance, in June 2018, the company launched the Sugar.IQ smart diabetes assistant app for the management of diabetes patients. This will benefit physicians by providing them insights into how the nutrition plan, medication regimen, and daily activities affect Glucose levels and help them in making treatment-related decisions. With its strong product pipeline and growth strategies, Medtronic is expected to enhance its leadership in the digital diabetes management market.

Roche Diagnostics

Roche is one of the leading providers of blood glucose monitoring systems in the digital diabetes management market. The company offers digital glucometers, diabetes management applications, and data management software. To maintain its position in this market, the company focuses on expanding its product portfolio through organic and inorganic strategies, such as product launches, collaborations, partnerships, agreements, and acquisitions. For instance, in 2017, the company acquired mySugr GmbH, which helped it to expand its product portfolio in the area of diabetes management apps. Also, in 2018, Roche partnered with various companies such as Wellthy Therapeutics Private Limited (India), Ieso Digital Health Ltd. (UK), and Care Innovations Ltd. (US) to integrate its existing portfolio and develop solutions for global, personalized management of diabetes by connecting patients and healthcare professionals to better control the disease.

Geographically, Roche has a strong presence in North America, Europe, and the Asia Pacific. Its strong distribution channels help it to cater to the rising demand for digital diabetes management devices and apps across the globe. However, increasingly stringent government regulations and global financial fluctuations are major threats to the company’s revenue generation.